Quick Answer: Wegovy progress follows a fairly predictable pattern tied to the titration schedule — modest changes in the first month as your body adjusts to a low dose, more noticeable appetite reduction and weight loss from months 2–4 as the dose increases, and the most significant cumulative results after reaching the 2.4mg maintenance dose around month 4 and continuing through month 12+. Progress that looks slower than someone else’s isn’t necessarily a problem — individual response varies meaningfully.
Whether you’re deciding if a 16-week titration schedule is worth committing to, or you’re a few weeks in and wondering if what you’re feeling is normal, here’s a realistic, stage-by-stage picture.
Month 1 (Weeks 1–4): The Adjustment Phase
Dose: 0.25mg, once weekly
This first month is about tolerance, not transformation. The starting dose is intentionally low, and its main purpose is letting your body adjust to semaglutide before increasing to a level that meaningfully affects appetite.
What’s typical:
- Mild nausea, bloating, or appetite changes, especially in the first 1–2 weeks
- Little to no significant weight change yet for many people
- Some people do notice reduced appetite even at this low dose — this varies a lot person to person
What’s not typical: severe vomiting, inability to keep fluids down, or symptoms that worsen rather than settle over the month. See our guide on Mounjaro side effects for the shared GLP-1 side effect pattern and when something needs medical attention rather than just monitoring.
If you’re deciding whether to start: this month is the least dramatic part of treatment. Don’t judge Wegovy’s effectiveness based on month 1 alone — it’s not designed to show its full effect yet.
Month 2 (Weeks 5–8): Appetite Changes Become More Noticeable
Dose: 0.5mg, increasing to 1mg partway through
This is usually when people start noticing a real difference in hunger and food intake, as the dose steps up.
What’s typical:
- More noticeable appetite reduction — smaller portions feel satisfying
- Some continued mild GI symptoms, particularly after each dose increase
- Visible, if modest, weight loss for many people by the end of this month
A realistic note: progress isn’t always linear. Some weeks show more change than others, and that’s normal biological variation, not a sign something’s off.
Month 3 (Weeks 9–12): Momentum Builds
Dose: 1mg, increasing to 1.7mg
By this stage, most people have a clearer sense of how their body responds to the medication, and side effects from earlier doses have often settled into something more manageable.
What’s typical:
- More consistent appetite suppression
- Continued gradual weight loss
- Old eating habits and portion sizes start to feel genuinely different, not just consciously restricted
Worth tracking: if you haven’t noticed any change in appetite or weight by the end of month 3, this is a reasonable point to discuss with your doctor — not because something is necessarily wrong, but because your treatment plan may benefit from review.
Month 4 (Weeks 13–16): Reaching Maintenance Dose
Dose: 1.7mg, increasing to 2.4mg (maintenance) by the end of this month
This marks the end of the titration schedule. From here, you’re on the dose that clinical trial data is actually built around.
What’s typical:
- The most significant weight loss phase for many patients begins around this point
- Side effects are often at their most settled, since your body has had 12+ weeks to adjust progressively
- A noticeably different relationship with food and portion sizes for most people by this stage
Months 5–12: The Maintenance Phase
Dose: 2.4mg, ongoing
This is where the STEP clinical trial data is most directly relevant: participants on the 2.4mg maintenance dose lost an average of 14.9% of body weight over 68 weeks (roughly 16 months) — but a meaningful portion of that curve happens in this maintenance window, not just the titration period.
| Month | What to Generally Expect |
|---|---|
| 5–6 | Continued steady weight loss; body composition changes become more visible |
| 7–9 | Weight loss often continues, sometimes at a slightly slower rate than the initial months |
| 10–12 | Approaching the plateau many patients experience as the body adjusts to its new baseline |
About plateaus: a slowdown in weight loss during this phase isn’t unusual and doesn’t necessarily mean the medication has “stopped working.” Metabolic adaptation to weight loss is a normal biological response, and this is a good time to discuss with your doctor whether adjustments to diet, activity, or your treatment plan would help — rather than assuming the plateau is permanent or unaddressable.
Beyond 12 Months: Longer-Term Considerations
Skin and facial changes: with significant weight loss over an extended period, some people notice loose or sagging skin, or a hollower facial appearance sometimes referred to as “Ozempic face.” These are separate from Wegovy’s side effects and relate to the weight loss itself — our guides on loose skin after weight loss and Ozempic face cover why this happens and what can help, if it becomes a concern for you.
Maintenance planning: the question of what happens if you stop treatment becomes relevant here. Weight regain is common without a sustainable maintenance plan, since Wegovy addresses appetite regulation rather than the underlying causes of weight gain alone — this is worth discussing with your doctor well before you consider stopping, not after.
A Note on Individual Variation
Everyone’s timeline on this page is a general pattern, not a personal guarantee. Some people lose weight faster than the average STEP trial figures; others slower. Factors like starting weight, diet alongside treatment, activity level, and individual metabolism all affect where you land on this curve. If your progress looks different from a friend’s or from what you’ve read online, that difference alone isn’t a red flag — consistent monitoring with your doctor is what actually tells you whether your treatment is working for you specifically.
Frequently Asked Questions
When will I start losing weight on Wegovy? Many people notice initial changes within the first month, though the most significant weight loss typically happens after reaching the higher doses around month 3–4 onward.
Is it normal to not lose much weight in the first month? Yes. The starting dose is low specifically to build tolerance, not to maximise weight loss yet. Don’t judge overall effectiveness based on month 1 alone.
What if I hit a plateau after several months? Plateaus are a normal part of weight loss on any treatment, related to metabolic adaptation. Discuss it with your doctor rather than assuming the medication has stopped working — adjustments to your plan may help.
How long until I reach the full 2.4mg dose? Around 16 weeks (about 4 months), following the standard titration schedule that increases every 4 weeks.
Does everyone lose the same amount of weight on the same timeline? No. The STEP trial average was 14.9% over 68 weeks, but individual results vary based on starting weight, lifestyle factors, and personal metabolism.
Should I combine Wegovy with a specific diet plan for better results? Wegovy is intended to be used alongside diet and lifestyle changes, not instead of them. Our diet plan guide for weight loss in Malaysia covers an approach that pairs well with GLP-1 treatment.
Bottom Line
Wegovy’s progress curve follows a fairly predictable shape — a quiet first month, building momentum through the titration schedule, and the most substantial results developing over the maintenance phase from month 4 onward. If your experience doesn’t match this exactly, that’s normal individual variation, not necessarily a problem. At CLEO Clinic, your progress is tracked with structured follow-up appointments throughout, so any part of your timeline that looks off can be reviewed and adjusted rather than left to guesswork. See our full Wegovy Malaysia guide for pricing and eligibility, or book a consultation to get started.
